- Report
- October 2024
- 193 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- February 2025
- 240 Pages
Global
From €2550EUR$2,690USD£2,130GBP
- Report
- April 2025
- 93 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- July 2024
- 175 Pages
Global
From €4739EUR$5,000USD£3,959GBP
- Report
- January 2025
- 135 Pages
Global
From €2843EUR$2,999USD£2,375GBP
- Report
- May 2024
- 137 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Report
- May 2024
- 137 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Clinical Trials
- December 2024
- 60 Pages
Global
From €1422EUR$1,500USD£1,188GBP
- Report
- October 2024
- 210 Pages
Global
From €7535EUR$7,950USD£6,295GBP
- Report
- October 2024
- 250 Pages
Global
From €4691EUR$4,949USD£3,919GBP
- Drug Pipelines
- August 2024
- 150 Pages
Global
From €2643EUR$2,789USD£2,208GBP
- Report
- August 2022
- 117 Pages
Global
From €4265EUR$4,500USD£3,563GBP
- Report
- January 2024
- 395 Pages
Global
From €7109EUR$7,500USD£5,939GBP
- Report
- November 2023
- 381 Pages
Global
€4734EUR$4,995USD£3,955GBP
- Report
- October 2024
Global
From €3317EUR$3,500USD£2,771GBP
- Report
- November 2021
- 844 Pages
Global
From €4739EUR$5,000USD£3,959GBP
- Book
- July 2009
- 1116 Pages

Phenytoin is a cardiovascular drug used to treat arrhythmias, or irregular heartbeats. It is also used to prevent seizures in people with epilepsy. Phenytoin works by slowing down the electrical signals in the brain that cause seizures. It is available in both generic and brand-name forms. The drug is available in both oral and intravenous forms.
Phenytoin is used to treat a variety of cardiovascular conditions, including atrial fibrillation, ventricular tachycardia, and Wolff-Parkinson-White syndrome. It is also used to prevent seizures in people with epilepsy. The drug is generally well-tolerated, but can cause side effects such as dizziness, drowsiness, and nausea.
The phenytoin market is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Mylan. Show Less Read more